• Home
  • Join Newsletter
  • Careers
  • Contact Us
Twitter
Facebook
LinkedIn
Google+
Soligenix, Inc.
  • About Us
    • Company Overview
    • Leadership
  • Pipeline
    • Overview
    • BioTherapeutics
    • Vaccines/BioDefense
    • Reference Literature
  • Investors
    • Corporate Fact Sheet (PDF)
    • SGX94 executive summary (PDF)
    • Analyst Coverage
    • SEC Filings
  • Partnering
  • News & Events

Sitemap

  • About Us
    • Company Overview
    • Leadership
      • Board of Directors
      • Executive Team
      • Scientific Advisors
        • Pediatric Crohn's Disease Medical Advisory Board
        • Radiation Enteritis Medical Advisory Board
        • North American GVHD Medical Advisory Board
        • European GVHD Medical Advisory Board
        • Oral Mucositis Medical Advisory Board
  • Pipeline
    • Overview
    • BioTherapeutics
      • SGX942 Oral Mucositis
      • SGX201 Radiation Enteritis
      • SGX203 Pediatric Crohn's Disease
      • orBec® Chronic GVHD Treatment
    • Vaccines/BioDefense
      • ThermoVax™ Heat Stabilization
      • VeloThrax™ Anthrax Vaccine
      • RiVax™ Ricin Toxin Vaccine
      • OrbeShield™ GI Acute Radiation Syndrome
    • Reference Literature
  • Investors
    • Corporate Fact Sheet (pdf)
    • SGX94 executive summary (PDF)
    • Analyst Coverage
    • Code of Ethics
    • SEC Filings
  • Partnering
    • In-Licensing
    • Out-Licensing
  • News & Events
    • Current Releases
    • Archive
  • Join Newsletter
  • Careers
  • Contact Us
  • Legal Notice
    • Policy On Financial Conflicts Of Interest In U.S. Public Health Service Funded Research
    • FCOI Disclosures
Website created by Princeton Internet Group, Inc. (PING)
Legal Notice | Sitemap | Copyright © 2013 Soligenix, Inc.